Trial record 1 of 1 for:    fibrosing colonopathy
Previous Study | Return to List | Next Study

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01652157
Recruitment Status : Recruiting
First Posted : July 27, 2012
Last Update Posted : March 8, 2018
Cystic Fibrosis Foundation Therapeutics
Digestive Care, Inc.
Janssen Research & Development, LLC
Forest Research Institute, Inc., an Allergan affiliate
Information provided by (Responsible Party):
AbbVie ( AbbVie (prior sponsor, Abbott) )

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 29, 2022
  Estimated Study Completion Date : July 29, 2022